Protein kinase C beta1 is implicated in the regulation of neuroblastoma cell growth and proliferation
(2000) In Cell Growth & Differentiation 11(12). p.641-648- Abstract
- To investigate a putative involvement of protein kinase C (PKC) isoforms in supporting neuroblastoma cell proliferation, SK-N-BE(2) neuroblastoma cells were transfected with expression vectors coding for the C2 and V5 regions from different PKC isoforms. These structures have been suggested to inhibit the activity of their corresponding PKC isoform. The PKC fragments were fused to enhanced green fluorescent protein to facilitate the detection of transfected cells. Expression of the C2 domain from a classical PKC isoform (PKCalpha), but not of C2 domains from novel PKCdelta or PKCepsilon, suppressed the number of neuroblastoma cells positive for cyclin A and bromodeoxyuridine incorporation. This indicates a role for a classical isoform in... (More)
- To investigate a putative involvement of protein kinase C (PKC) isoforms in supporting neuroblastoma cell proliferation, SK-N-BE(2) neuroblastoma cells were transfected with expression vectors coding for the C2 and V5 regions from different PKC isoforms. These structures have been suggested to inhibit the activity of their corresponding PKC isoform. The PKC fragments were fused to enhanced green fluorescent protein to facilitate the detection of transfected cells. Expression of the C2 domain from a classical PKC isoform (PKCalpha), but not of C2 domains from novel PKCdelta or PKCepsilon, suppressed the number of neuroblastoma cells positive for cyclin A and bromodeoxyuridine incorporation. This indicates a role for a classical isoform in regulating proliferation of these cells. Among the V5 fragments from PKCalpha, PKCbetaI, and PKCbetaII, the PKCbetaI V5 had the most suppressive effect on proliferation markers, and this fragment also displaced PKCbetaI from the nucleus. Furthermore, a PKCbeta-specific inhibitor, LY379196, suppressed the phorbol ester- and serum-supported growth of neuroblastoma cells. There was a marked enhancement by LY379196 of the growth-suppressive and/or cytotoxic effects of paclitaxel and vincristine. These results indicate that PKCbetaI has a positive effect on the growth and proliferation of neuroblastoma cells and demonstrate that inhibition of PKCbeta may be used to enhance the effect of microtubule-interacting anticancer agents on neuroblastoma cells. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1116174
- author
- Svensson, Karin ; Zeidman, Ruth LU ; Trollér, Ulrika LU ; Schultz, Anna LU and Larsson, Christer LU
- organization
- publishing date
- 2000
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Cell Growth & Differentiation
- volume
- 11
- issue
- 12
- pages
- 641 - 648
- publisher
- American Association for Cancer Research
- external identifiers
-
- pmid:11149599
- scopus:0034524218
- ISSN
- 1044-9523
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Molecular Medicine (013031200), Tumour Cell Biology (013017530), Division of Molecular Medicine and Gene Therapy (013022010)
- id
- e4f5d1d6-242a-4e7a-b722-7911e786e485 (old id 1116174)
- alternative location
- http://cgd.aacrjournals.org/cgi/content/full/11/12/641
- date added to LUP
- 2016-04-01 16:17:44
- date last changed
- 2022-01-28 18:39:30
@article{e4f5d1d6-242a-4e7a-b722-7911e786e485, abstract = {{To investigate a putative involvement of protein kinase C (PKC) isoforms in supporting neuroblastoma cell proliferation, SK-N-BE(2) neuroblastoma cells were transfected with expression vectors coding for the C2 and V5 regions from different PKC isoforms. These structures have been suggested to inhibit the activity of their corresponding PKC isoform. The PKC fragments were fused to enhanced green fluorescent protein to facilitate the detection of transfected cells. Expression of the C2 domain from a classical PKC isoform (PKCalpha), but not of C2 domains from novel PKCdelta or PKCepsilon, suppressed the number of neuroblastoma cells positive for cyclin A and bromodeoxyuridine incorporation. This indicates a role for a classical isoform in regulating proliferation of these cells. Among the V5 fragments from PKCalpha, PKCbetaI, and PKCbetaII, the PKCbetaI V5 had the most suppressive effect on proliferation markers, and this fragment also displaced PKCbetaI from the nucleus. Furthermore, a PKCbeta-specific inhibitor, LY379196, suppressed the phorbol ester- and serum-supported growth of neuroblastoma cells. There was a marked enhancement by LY379196 of the growth-suppressive and/or cytotoxic effects of paclitaxel and vincristine. These results indicate that PKCbetaI has a positive effect on the growth and proliferation of neuroblastoma cells and demonstrate that inhibition of PKCbeta may be used to enhance the effect of microtubule-interacting anticancer agents on neuroblastoma cells.}}, author = {{Svensson, Karin and Zeidman, Ruth and Trollér, Ulrika and Schultz, Anna and Larsson, Christer}}, issn = {{1044-9523}}, language = {{eng}}, number = {{12}}, pages = {{641--648}}, publisher = {{American Association for Cancer Research}}, series = {{Cell Growth & Differentiation}}, title = {{Protein kinase C beta1 is implicated in the regulation of neuroblastoma cell growth and proliferation}}, url = {{http://cgd.aacrjournals.org/cgi/content/full/11/12/641}}, volume = {{11}}, year = {{2000}}, }